Development of tat - conjugated dendrimer for transdermal DNA vaccine delivery

PURPOSE: In order to enhance cellular uptake and to facilitate transdermal delivery of DNA vaccine, polyamidoamine (PAMAM) dendrimers conjugated with HIV transactivator of transcription (TAT) was developed. METHODS: First, the plasmid DNA (pIRES-H5/GFP) nanoparticle was formulated using PAMAM d...

Full description

Bibliographic Details
Main Authors: Bahadoran, Azadeh, Moeini, Hassan, Bejo, Mohd Hair, Hussein, Mohd Zobir, Omar, Abdul Rahman
Format: Article
Language:English
Published: Canadian Society for Pharmaceutical Sciences 2016
Online Access:http://psasir.upm.edu.my/id/eprint/55505/
http://psasir.upm.edu.my/id/eprint/55505/1/Development%20of%20Tat-Conjugated%20Dendrimer%20for%20Transdermal%20DNA%20Vaccine%20Delivery..pdf
_version_ 1848852821109112832
author Bahadoran, Azadeh
Moeini, Hassan
Bejo, Mohd Hair
Hussein, Mohd Zobir
Omar, Abdul Rahman
author_facet Bahadoran, Azadeh
Moeini, Hassan
Bejo, Mohd Hair
Hussein, Mohd Zobir
Omar, Abdul Rahman
author_sort Bahadoran, Azadeh
building UPM Institutional Repository
collection Online Access
description PURPOSE: In order to enhance cellular uptake and to facilitate transdermal delivery of DNA vaccine, polyamidoamine (PAMAM) dendrimers conjugated with HIV transactivator of transcription (TAT) was developed. METHODS: First, the plasmid DNA (pIRES-H5/GFP) nanoparticle was formulated using PAMAM dendrimer and TAT peptide and then characterized for surface charge, particle size, DNA encapsulation and protection of the pIRES-H5/GFP DNA plasmid to enzymatic digestion. Subsequently, the potency of the TAT-conjugated dendrimer for gene delivery was evaluated through in vitro transfection into Vero cells followed by gene expression analysis including western blotting, fluorescent microscopy and PCR. The effect of the TAT peptide on cellular uptake of DNA vaccine was studied by qRT-PCR and flow cytometry. Finally, the ability of TAT-conjugated PAMAM dendrimer for transdermal delivery of the DNA plasmid was assessed through artificial membranes followed by qRT-PCR and flow cytometry. RESULTS: TAT-conjugated PAMAM dendrimer showed the ability to form a compact and nanometre-sized polyplexes with the plasmid DNA, having the size range of 105 to 115 nm and a positive charge of +42 to +45 mV over the N/P ratio of 6:1(+/-). In vitro transfection analysis into Vero cells confirms the high potency of TAT-conjugated PAMAM dendrimer to enhance the cellular uptake of DNA vaccine. The permeability value assay through artificial membranes reveals that TAT-conjugated PAMAM has more capacity for transdermal delivery of the DNA compared to unmodified PAMAM dendrimer (P<0.05). CONCLUSIONS: The findings of this study suggest that TAT-conjugated PAMAM dendrimer is a promising non-viral vector for transdermal use.This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page.
first_indexed 2025-11-15T10:44:10Z
format Article
id upm-55505
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T10:44:10Z
publishDate 2016
publisher Canadian Society for Pharmaceutical Sciences
recordtype eprints
repository_type Digital Repository
spelling upm-555052017-09-13T10:09:16Z http://psasir.upm.edu.my/id/eprint/55505/ Development of tat - conjugated dendrimer for transdermal DNA vaccine delivery Bahadoran, Azadeh Moeini, Hassan Bejo, Mohd Hair Hussein, Mohd Zobir Omar, Abdul Rahman PURPOSE: In order to enhance cellular uptake and to facilitate transdermal delivery of DNA vaccine, polyamidoamine (PAMAM) dendrimers conjugated with HIV transactivator of transcription (TAT) was developed. METHODS: First, the plasmid DNA (pIRES-H5/GFP) nanoparticle was formulated using PAMAM dendrimer and TAT peptide and then characterized for surface charge, particle size, DNA encapsulation and protection of the pIRES-H5/GFP DNA plasmid to enzymatic digestion. Subsequently, the potency of the TAT-conjugated dendrimer for gene delivery was evaluated through in vitro transfection into Vero cells followed by gene expression analysis including western blotting, fluorescent microscopy and PCR. The effect of the TAT peptide on cellular uptake of DNA vaccine was studied by qRT-PCR and flow cytometry. Finally, the ability of TAT-conjugated PAMAM dendrimer for transdermal delivery of the DNA plasmid was assessed through artificial membranes followed by qRT-PCR and flow cytometry. RESULTS: TAT-conjugated PAMAM dendrimer showed the ability to form a compact and nanometre-sized polyplexes with the plasmid DNA, having the size range of 105 to 115 nm and a positive charge of +42 to +45 mV over the N/P ratio of 6:1(+/-). In vitro transfection analysis into Vero cells confirms the high potency of TAT-conjugated PAMAM dendrimer to enhance the cellular uptake of DNA vaccine. The permeability value assay through artificial membranes reveals that TAT-conjugated PAMAM has more capacity for transdermal delivery of the DNA compared to unmodified PAMAM dendrimer (P<0.05). CONCLUSIONS: The findings of this study suggest that TAT-conjugated PAMAM dendrimer is a promising non-viral vector for transdermal use.This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page. Canadian Society for Pharmaceutical Sciences 2016 Article PeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/55505/1/Development%20of%20Tat-Conjugated%20Dendrimer%20for%20Transdermal%20DNA%20Vaccine%20Delivery..pdf Bahadoran, Azadeh and Moeini, Hassan and Bejo, Mohd Hair and Hussein, Mohd Zobir and Omar, Abdul Rahman (2016) Development of tat - conjugated dendrimer for transdermal DNA vaccine delivery. Journal of Pharmacy and Pharmaceutical Sciences, 19 (3). pp. 325-338. ISSN 1482-1826 http://www.ualberta.ca/~csps/Journals/JPPS.htm 10.18433/J3G31Q
spellingShingle Bahadoran, Azadeh
Moeini, Hassan
Bejo, Mohd Hair
Hussein, Mohd Zobir
Omar, Abdul Rahman
Development of tat - conjugated dendrimer for transdermal DNA vaccine delivery
title Development of tat - conjugated dendrimer for transdermal DNA vaccine delivery
title_full Development of tat - conjugated dendrimer for transdermal DNA vaccine delivery
title_fullStr Development of tat - conjugated dendrimer for transdermal DNA vaccine delivery
title_full_unstemmed Development of tat - conjugated dendrimer for transdermal DNA vaccine delivery
title_short Development of tat - conjugated dendrimer for transdermal DNA vaccine delivery
title_sort development of tat - conjugated dendrimer for transdermal dna vaccine delivery
url http://psasir.upm.edu.my/id/eprint/55505/
http://psasir.upm.edu.my/id/eprint/55505/
http://psasir.upm.edu.my/id/eprint/55505/
http://psasir.upm.edu.my/id/eprint/55505/1/Development%20of%20Tat-Conjugated%20Dendrimer%20for%20Transdermal%20DNA%20Vaccine%20Delivery..pdf